drugset / Trial / NCT02511145

Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration

NCT02511145

Phase 1 Completed 10 enrolled Galderma R&D
RandomizedSingle-groupOpen-labelOther

Summary

Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques.

Timeline

Start
2014-02
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator methyl aminolevulinate Small molecule

Indications

No indication recorded.